Pideka Group (Pideka Group) Cash-to-Debt : 0.03 (As of Sep. 2021)

View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Pideka Group's cash to debt ratio for the quarter that ended in Sep. 2021 was 0.03.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Pideka Group couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2021.

The historical rank and industry rank for Pideka Group's Cash-to-Debt or its related term are showing as below:

CIMVF's Cash-to-Debt is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.95
* Ranked among companies with meaningful Cash-to-Debt only.

Pideka Group Cash-to-Debt Historical Data

The historical data trend for Pideka Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Pideka Group Cash-to-Debt Chart

Pideka Group Annual Data

Trend

Cash-to-Debt

Pideka Group Quarterly Data
	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21
Cash-to-Debt	Get a 7-Day Free Trial			N/A	N/A	0.17	0.04	0.03

Competitive Comparison of Pideka Group's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Pideka Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pideka Group's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pideka Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Pideka Group's Cash-to-Debt falls into.

Pideka Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Pideka Group's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Pideka Group's Cash to Debt Ratio for the quarter that ended in Sep. 2021 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.349	/	(1.671	+	9.002)
	=	0.03

Pideka Group (OTCPK:CIMVF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Pideka Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Pideka Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pideka Group (Pideka Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2

Website

https://www.ikanikfarms.com

Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.